Invention Grant
- Patent Title: Phage therapy
-
Application No.: US17153911Application Date: 2021-01-21
-
Publication No.: US11779617B2Publication Date: 2023-10-10
- Inventor: Flavie Pouillot , Helene Blois
- Applicant: PHERECYDES PHARMA
- Applicant Address: FR Romainville
- Assignee: PHERECYDES PHARMA
- Current Assignee: PHERECYDES PHARMA
- Current Assignee Address: FR Romainville
- Agency: SALIWANCHIK, LLOYD & EISENSCHENK
- Priority: EP 306788 2014.11.07
- Main IPC: A61K35/76
- IPC: A61K35/76 ; C12N7/00
Abstract:
The present invention relates to bacteriophage therapy. More particularly, the present invention relates to novel bacteriophages having a high specificity against Pseudomonas aeruginosa strains, their manufacture, components thereof, compositions comprising the same and the uses thereof in phage therapy.
Public/Granted literature
- US20210228659A1 PHAGE THERAPY Public/Granted day:2021-07-29
Information query
